Pal S - Search Results

1

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma.

Donskov F, Motzer RJ, Voog E, Hovey E, Grüllich C, Nott LM, Cuff K, Gil T, Jensen NV, Chevreau C, Negrier S, Depenbusch R, Bergmann L, Cornelio I, Champsaur A, Escudier B, Pal S, Powles T, Choueiri TK. Donskov F, et al. Among authors: pal s. Eur J Cancer. 2020 Feb;126:1-10. doi: 10.1016/j.ejca.2019.10.032. Epub 2019 Dec 27. Eur J Cancer. 2020. PMID: 31887537 Free PMC article. Clinical Trial.

2

New therapies for castrate-resistant prostate cancer.

Williams SB, Lay AH, Lau CS, Josephson DY, Wilson TG, Choueiri TK, Pal SK. Williams SB, et al. Among authors: pal sk. Expert Opin Pharmacother. 2011 Sep;12(13):2069-74. doi: 10.1517/14656566.2011.590133. Epub 2011 Jun 11. Expert Opin Pharmacother. 2011. PMID: 21663529 Review.

3

Systemic therapies for metastatic renal cell carcinoma in older adults.

Pal SK, Vanderwalde A, Hurria A, Figlin RA. Pal SK, et al. Drugs Aging. 2011 Aug 1;28(8):635-49. doi: 10.2165/11592880-000000000-00000. Drugs Aging. 2011. PMID: 21812499 Free PMC article. Review.

4

Role of surgery for locally advanced and metastatic renal cell carcinoma.

Torrey R, Spiess PE, Pal SK, Josephson D. Torrey R, et al. J Natl Compr Canc Netw. 2011 Sep 1;9(9):985-93. doi: 10.6004/jnccn.2011.0083. J Natl Compr Canc Netw. 2011. PMID: 21917623 Review.

5

Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis.

Pal SK, Jones JO, Carmichael C, Saikia J, Hsu J, Liu X, Figlin RA, Twardowski P, Lau C. Pal SK, et al. Urol Oncol. 2013 Nov;31(8):1826-31. doi: 10.1016/j.urolonc.2012.04.007. Epub 2012 May 17. Urol Oncol. 2013. PMID: 22608544 Free PMC article.

6

Comprehensive overview of axitinib development in solid malignancies: focus on metastatic renal cell carcinoma.

Carmichael C, Lau C, Josephson DY, Pal SK. Carmichael C, et al. Clin Adv Hematol Oncol. 2012 May;10(5):307-14. Clin Adv Hematol Oncol. 2012. PMID: 22706540 Review.

7

Quality of life in patients with metastatic renal cell carcinoma: assessment of long-term survivors.

Carmichael C, Yuh BE, Sun V, Lau C, Hsu J, Saikia J, Liu X, Wilson T, Ferrell B, Pal SK. Carmichael C, et al. Clin Genitourin Cancer. 2013 Jun;11(2):149-54. doi: 10.1016/j.clgc.2012.09.006. Epub 2012 Oct 9. Clin Genitourin Cancer. 2013. PMID: 23058499 Free PMC article. Clinical Trial.

8

Differentiating mTOR inhibitors in renal cell carcinoma.

Pal SK, Quinn DI. Pal SK, et al. Cancer Treat Rev. 2013 Nov;39(7):709-19. doi: 10.1016/j.ctrv.2012.12.015. Epub 2013 Feb 21. Cancer Treat Rev. 2013. PMID: 23433636 Free PMC article. Review.

9

Sequential treatment strategies and combination therapy regimens in metastatic renal cell carcinoma.

Pal SK, Vogelzang NJ. Pal SK, et al. Clin Adv Hematol Oncol. 2013 Mar;11(3):146-55. Clin Adv Hematol Oncol. 2013. PMID: 23598982 Review.

10

A gap in disease-specific survival between younger and older adults with de novo metastatic renal cell carcinoma: results of a SEER database analysis.

Nelson RA, Vogelzang N, Pal SK. Nelson RA, et al. Clin Genitourin Cancer. 2013 Sep;11(3):303-10. doi: 10.1016/j.clgc.2013.04.011. Epub 2013 May 4. Clin Genitourin Cancer. 2013. PMID: 23647940 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,649 results

Search Page

Filters